Material Agreements

Amentum Holdings, Inc. entered into First Amendment to Credit Agreement with JPMorgan Chase Bank, N.A. valued at New five-year senior secured term loan A facility of $1.400 billion, new senior secured term loan B (effective 2026-04-24).

“Amentum Holdings, Inc., a Delaware corporation (“Amentum”), entered into the First Amendment (the “First Amendment”), dated as of such date, among Amentum, Amentum Services, Inc., a Delaware corporation (“Amentum Services”), Amentum Technology, Inc., a Tennessee corporation (“Amentum Technology”), the other loan parties party thereto, the lenders party thereto, the issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), which amends the Credit Agreement dated as of September 27, 2024”

Blackstone Private Real Estate Credit & Income Fund entered into Revolving Credit Facility with Wells Fargo Bank, N.A. as administrative agent valued at $150,000,000 (effective 2026-04-23).

“On April 23, 2026, Blackstone Private Real Estate Credit and Income Fund (the “Fund”) and BREC Holdings, LP (the “Borrower”) entered into a revolving credit facility (the “Revolving Credit Facility”) with Wells Fargo Bank, N.A. as administrative agent (the “Administrative Agent”).”

SharonAI Holdings Inc. entered into Securities Purchase Agreement with certain qualified institutional buyers valued at $350 million (effective 2026-04-26).

“On April 26, 2026, SharonAI Holdings Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain qualified institutional buyers relating to the private offering (the “Offering”) of $350 million aggregate principal amount of the Company’s 6.00% Convertible Senior Notes due 2031 (the “Notes”).”

FLEXSTEEL INDUSTRIES INC entered into Stock Repurchase Agreement with F. Brooks Bertsch and certain family related entities valued at approximately $60.2 million (effective 2026-04-26).

“On April 26, 2026, Flexsteel Industries, Inc. (the “Company”) entered into a stock repurchase agreement (the “Stock Repurchase Agreement”) with F. Brooks Bertsch, a director of the Company, and certain family related entities listed on Schedule 1 thereto (the “Stockholders”) for the purchase by the Company of 1,279,870 shares of the Company’s common stock, $1.00 par value per share (the “Common Stock”) from the Stockholders in a privately-negotiated transaction at a purchase price of $47.00 per share and for a total purchase price of approximately $60.2 million.”

GENUINE PARTS CO amended Seventh Amendment with JPMorgan Chase Bank, N.A., as administrative agent, domestic swing line lender and L/C issuer, JPMorgan Chase Bank, N.A., acting through its Toronto Branch, as Canadian swing line lender and the other lenders valued at $500 million and a Delayed Draw Term Loan Facility in an aggregate principal amount of $500 million (effective 2026-04-28).

“On April 28, 2026, Genuine Parts Company (the "Company") entered into a seventh amendment (the "Seventh Amendment") to its existing Syndicated Facility Agreement, dated October 30, 2020, by and among the Company, UAP, Inc., certain designated Company subsidiaries, as borrowers, JPMorgan Chase Bank, N.A., as administrative agent, domestic swing line lender and L/C issuer, JPMorgan Chase Bank, N.A., acting through its Toronto Branch, as Canadian swing line lender and the other lenders and L/C issuers from time to time party thereto.”

AMERICAN AIRLINES, INC. entered into a notes offering valued at $905,038,000 aggregate face amount of Class A enhanced equipment trust certificates and $235,765,000 (effective 2026-04-27).

“On April 27, 2026, American Airlines, Inc. announced the pricing of its offering of (i) $905,038,000 aggregate face amount of Class A enhanced equipment trust certificates and (ii) $235,765,000 aggregate face amount of Class B enhanced equipment trust certificates.”

DYNEX CAPITAL INC amended Amendment No. 9 with BTIG, LLC, Citizens JMP Securities, LLC, Goldman Sachs & Co. LLC, JonesTrading Institutional Services LLC, J.P. Morgan Securities LLC, Keefe, Bruyette & Woods, Inc., Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, and Wells Fargo Securities, LLC (effective 2026-04-28).

“On April 28, 2026, Dynex Capital, Inc. (the “Company”), entered into amendment no. 9 (“Amendment No. 9”) to the distribution agreement, dated June 29, 2018, as amended on May 31, 2019, August 3, 2021, June 3, 2022, February 10, 2023, October 29, 2024, May 1, 2025, July 29, 2025, and January 27, 2026 (the “Agreement” and, as amended by Amendment No. 9, the “Amended Agreement”), by and among the Company, on the one hand, and BTIG, LLC, Citizens JMP Securities, LLC, Goldman Sachs & Co. LLC (“Goldman Sachs”), JonesTrading Institutional Services LLC, J.P. Morgan Securities LLC, Keefe, Bruyette & Woods, Inc., Morgan Stanley & Co. LLC (“Morgan Stanley”), RBC Capital Markets, LLC, UBS Securities LLC, and Wells Fargo Securities, LLC (collectively the “Sales Agents” and each individually a “Sales Agent”), on the other hand, pursuant to which shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), may be offered and sold through the Sales Agents in transactions that are”

Sleep Number Corp amended Forbearance Agreement and Thirteenth Amendment with U.S. Bank National Association valued at $25 million term loan facility (effective 2026-04-27).

“On April 27, 2026, Sleep Number Corporation, a Minnesota corporation (“Sleep Number”), entered into a Forbearance Agreement and Thirteenth Amendment (the “Thirteenth Amendment”) amending the Amended and Restated Credit and Security Agreement, dated as of February 14, 2018”

PATTERSON UTI ENERGY INC amended Assignment and Amendment No. 1 to Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the letter of credit issuers and lenders party thereto (effective 2026-04-24).

“On April 24, 2026, Patterson-UTI Energy, Inc. (the “Company”) entered into the Assignment and Amendment No. 1 to Second Amended and Restated Credit Agreement (the “Amendment”), which amends the Second Amended and Restated Credit Agreement, dated as of January 31, 2025, by and among the Company, Wells Fargo Bank, National Association, as administrative agent, and the letter of credit issuers and lenders party thereto (as amended, the “Credit Agreement”).”

MCKESSON CORP terminated Existing Credit Facility (effective 2026-04-24).

“The Existing Credit Facility was scheduled to mature in November 2029 and provided a revolving line of credit available of up to $4.0 billion”

MCKESSON CORP terminated Existing 364-Day Credit Facility (effective 2026-04-24).

“The Existing 364-Day Credit Facility was scheduled to mature in May 2026 and provided a revolving line of credit of up to $1.0 billion.”

MCKESSON CORP entered into Credit Agreement with Bank of America, N.A. valued at $5.0 billion (effective 2026-04-24).

“On April 24, 2026, McKesson Corporation ("McKesson" or the "Company") entered into a Credit Agreement (the "New Revolving Credit Facility") among the Company, as borrower, the lenders party thereto, Bank of America, N.A., as administrative agent, and the other parties thereto.”

US ENERGY CORP entered into Helium Sales Agreement with an investment-grade industrial gas company with global distribution infrastructure valued at fixed base price of $285.00 per thousand standard cubic feet (effective 2026-04-24).

“On April 24, 2026, U.S. Energy Corp. (“U.S. Energy,” “we,” “us” or the “Company”) entered into a Helium Sales Agreement (the “Helium Sales Agreement”) with an investment-grade industrial gas company with global distribution infrastructure (the “Counterparty”) for the sale of contained helium to be produced at the Company’s helium purification plant being constructed near Oilmont, Montana”

BENTLEY SYSTEMS INC amended First Amendment and Incremental Facility Agreement with PNC Bank, National Association, as administrative agent valued at $550 million senior secured term loan maturing October 18, 2029, with interest at Alternate Base Rat (effective 2026-04-23).

“On April 23, 2026, Bentley Systems, Incorporated (the “ Company ”) entered into a First Amendment and Incremental Facility Agreement, dated as of April 23, 2026 (the “ First Amendment ”), by and among the Company, the subsidiary loan parties thereto, the lenders party thereto and PNC Bank, National Association, as administrative agent, which amends that certain Second Amended and Restated Credit Agreement, dated as of October 18, 2024 (the “ Credit Agreement ”), by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent.”

BIOMARIN PHARMACEUTICAL INC entered into Merger Agreement with Amicus valued at Amicus merged with and into Merger Sub with Amicus continuing as the surviving corporation and as a (effective 2026-04-27).

“ursuant to the terms of the Merger Agreement, Amicus merged with and into Merger Sub (the “ Merger ”) with Amicus continuing as the surviving corporation and as a wholly owned subsidiary of BioMarin.”

CME GROUP INC. amended Amendment No. 11 to the 364-Day Multi-Currency Credit Facility (Existing 364-Day Credit Facility) with Bank of America, N.A. valued at $7 billion multi-currency revolving secured credit facility, eligible to be increased to $10 billion (effective 2026-04-22).

“Item 1.01 Entry into a Material Definitive Agreement. Clearing House Credit Facility Effective as of April 22, 2026, Chicago Mercantile Exchange Inc. ("CME") entered into an amendment ("Amendment No. 11") to its 364-day multi-currency credit facility (the "364-Day Credit Facility") with Bank of America, N.A., in its capacity as Administrative Agent, Citibank, N.A., in its capacity as Collateral Agent and Collateral Monitoring Agent, and the banks party thereto. The 364-Day Credit Facility as amended by Amendment No. 11 is referred to as the "Existing 364-Day Credit Facility." The Existing 364-Day Credit Facility is for a multi-currency revolving secured credit facility of $7 billion (which is eligible to be increased to $10 billion). The proceeds of the Existing 364-Day Credit Facility may be used to provide temporary liquidity in the unlikely event a clearing firm fails to promptly discharge an obligation to the clearing house operated by CME, in the event of a liquidity constraint or”

Riot Platforms, Inc. entered into Second Amended and Restated Credit Agreement with Coinbase Credit, Inc. valued at $200 million (effective 2026-04-21).

“On April 21, 2026, Riot Platforms, Inc. (the “ Company ”) entered into a second amended and restated credit agreement (the “ Second Amended and Restated Credit Agreement ”) by and between the Company, as the borrower, and Coinbase Credit, Inc., as lender, collateral agent, and administrative agent (the “ Lender ” and together with the Company, the “ Parties ”).”

AMICUS THERAPEUTICS, INC. terminated Amicus Credit Agreement (effective 2026-04-27).

“On April 27, 2026, in connection with the Merger, the Company repaid in full all outstanding indebtedness and all other amounts due and payable and terminated all commitments under that certain Loan Agreement, dated October 2, 2023, (as amended, restated, amended and restated, supplemented and otherwise modified from time to time prior to the Closing Date, the “ Amicus Credit Agreement ”), by and among the Company, each of its subsidiaries party thereto, as guarantors, Blackstone Alternative Credit Advisors LP, Blackstone Life Sciences Advisors L.L.C., certain lenders from time to time party thereto and Wilmington Trust, National Association, as agent for the lenders.”

Brookfield Oaktree Holdings, LLC entered into Distribution Agreement with Brookfield Oaktree Holdings Canada Inc. (effective 2026-04-20).

“On April 20, 2026, Brookfield Oaktree Holdings, LLC, a Delaware limited liability company (“BOH”), entered into a distribution agreement (the “Distribution Agreement”) with Brookfield Oaktree Holdings Canada Inc., a corporation incorporated under the laws of the Province of Ontario (“BOHCI”).”

Workhorse Group Inc. amended Omnibus Amendment No. 1 to Credit Agreements with Motive GM Holdings II LLC valued at from $10,000,000 to $20,000,000 (effective 2026-04-25).

“On April 25, 2026, Workhorse Group Inc. (“Workhorse” or the “Company”) entered into an Omnibus Amendment No. 1 to Credit Agreements (the “Omnibus Amendment”), which amends the Company’s (i) Credit Agreement (Customer Orders) (the “Customer Order Credit Agreement”) and (ii) Credit Agreement (Cash Flow) (the “Cash Flow Credit Agreement” and together with the Customer Order Credit Agreement, the “Credit Agreements” and such transactions, collectively, the “Closing Debt Financing”), each dated as of December 15, 2025, by and among Workhorse, as borrower, certain subsidiaries of Workhorse, as guarantors, and Motive GM Holdings II LLC (“MGMH”), as lender.”

GAMCO Natural Resources, Gold & Income Trust entered into Sales Agreement with G.research, LLC valued at up to 1,000,000 common shares (effective 2026-04-22).

“On April 22, 2026, GAMCO Natural Resources, Gold & Income Trust (NYSE: GNT) (the “Fund”) entered into a sales agreement (the “Sales Agreement”) with G.research, LLC (the “Sales Manager”), pursuant to which the Fund may offer and sell up to 1,000,000 common shares of beneficial interest of the Fund”

AUDDIA INC. entered into Engagement Letter with Dawson James Securities, Inc. valued at 7.0% of gross proceeds (effective 2026-03-04).

“Pursuant to an engagement letter, dated as of March 4, 2026, as amended April 23, 2026 (the "Engagement Letter"), by and between the Company and Dawson James Securities, Inc. (the "Placement Agent"), the Company has agreed to pay the Placement Agent a total cash fee equal to 7.0% of the gross proceeds received in the Offering.”

AUDDIA INC. entered into Securities Purchase Agreement with certain institutional investors valued at $12,000,000 (effective 2026-04-24).

“On April 24, 2026, Auddia Inc. (the "Company") commenced a public offering for the issuance and sale of an aggregate of: (i) 1,405,006 shares (the "Shares") of the Company's common stock, $0.001 par value (the "Common Stock"), (ii) pre-funded warrants (the "Pre-funded Warrants") to purchase up to 3,679,737 shares of Common Stock and (iii) accompanying warrants (the "Common Warrants" and together with the Shares and the Pre-funded Warrants, the "Securities") to purchase up to 5,084,743 shares of Common Stock (the "Offering"). In connection with the Offering, the Company, entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain institutional investors (the "Purchasers").”

National Healthcare Properties, Inc. entered into Underwriting Agreement with Wells Fargo Securities, LLC, Morgan Stanley & Co. LLC and BMO Capital Markets Corp., as representatives of the several underwriters (effective 2026-04-21).

“On April 23, 2026, National Healthcare Properties, Inc. (the “Company”) closed its registered underwritten public offering (the “Offering”) of 38,500,000 shares of Class A common stock, $0.01 par value per share (the “Class A Common Stock”) pursuant to its registration statement on Form S-11 (File No. 333-294895) (the “Registration Statement”) under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the Offering, the Company entered into an Underwriting Agreement, dated April 21, 2026, by and among the Company, National Healthcare Properties Operating Partnership, L.P. (the “Operating Partnership”), Wells Fargo Securities, LLC, Morgan Stanley & Co. LLC and BMO Capital Markets Corp., as representatives of the several underwriters named therein (the “Underwriting Agreement”).”

AB Private Credit Investors Corp amended Amendment with HSBC Bank USA, National Association valued at increased the Fund’s facility sublimit from $35,000,000 to $42,000,000 (effective 2026-04-22).

“On April 22, 2026, AB Private Credit Investors Corporation (the “ Fund ”) entered into an amendment (the “ Amendment ”) to the credit agreement establishing its revolving credit facility (the “ Credit Facility ”) with HSBC Bank USA, National Association, as the administrative agent and a lender, and each of the banks a party thereto.”

SiteOne Landscape Supply, Inc. amended First Amendment to Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at Extend final scheduled maturity to April 22, 2031, increase letter of credit sublimit from $30 milli (effective 2026-04-22).

“On April 22, 2026, certain subsidiaries of SiteOne Landscape Supply, Inc. entered into the First Amendment to Amended and Restated Credit Agreement, dated as of April 22, 2026 (the “First Amendment”), by and among SiteOne Landscape Supply Holding, LLC and SiteOne Landscape Supply, LLC, as borrowers (collectively, the “Borrowers”), JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, swingline lender and issuing lender (the “Agent”) and the several banks and other financial institutions party thereto.”

Fulcrum Therapeutics, Inc. terminated CAMP4 License with CAMP4 Therapeutics Corp. (effective 2026-04-23).

“On April 23, 2026, Fulcrum Therapeutics, Inc., or Fulcrum, provided written notice to CAMP4 Therapeutics Corp., or CAMP4, of termination of the License Agreement dated July 5, 2023, between Fulcrum and CAMP4, or the CAMP4 License, which termination will be effective in accordance with the terms of such agreement.”

InMed Pharmaceuticals Inc. amended Wainwright Preferred Investment Option Amending Agreements with affiliates of H.C. Wainwright & Co., LLC (effective 2026-04-24).

“On April 24, 2026, the Company entered into Preferred Investment Option Amending Agreements (the “Wainwright Preferred Investment Option Amending Agreements”) with each Wainwright Party to amend the Wainwright Exercise Prices contained in each Wainwright Preferred Investment Option to $0.80.”

InMed Pharmaceuticals Inc. amended Sabby Preferred Investment Option Amending Agreement with Sabby Volatility Warrant Master Fund, Ltd. (effective 2026-04-21).

“On April 21, 2026, the Company entered into a Preferred Investment Option Amending Agreement (the “Sabby Preferred Investment Option Amending Agreement”) with Sabby to amend the Sabby Exercise Price contained in each Sabby Preferred Investment Option from $2.436 to $0.80.”

Morgan Stanley Direct Lending Fund amended First Amendment to Amended and Restated Senior Secured Revolving Credit Agreement with Truist Bank valued at Extends commitment termination date to April 23, 2030 and maturity date to April 23, 2031 (effective 2026-04-23).

“On April 23, 2026, Morgan Stanley Direct Lending Fund (the “Company”) entered into an amendment to that certain Amended and Restated Senior Secured Revolving Credit Agreement (the “First Amendment”) with the Company, as a borrower, Truist Bank (“Truist”), as administrative agent, the subsidiary guarantors party thereto, and the lenders and issuing banks party thereto, which amends that certain Amended and Restated Senior Secured Revolving Credit Agreement, dated as of February 25, 2025.”

Driven Brands Holdings Inc. amended Amendment to Credit Agreement with JPMorgan Chase Bank, N.A. valued at amendment to revolving credit facility providing limited waiver and extending deadlines for delivery (effective 2026-04-24).

“On April 24, 2026, Driven Holdings Parent LLC (“Holdings”) and Driven Holdings, LLC (“Borrower”), indirect wholly-owned subsidiaries of Driven Brands Holdings Inc. (the “Company”), entered into an amendment (the “Amendment”) that also provides for a limited waiver to their revolving credit facility under the Credit Agreement, dated as of May 27, 2021 (as amended, restated, supplemented, or otherwise modified, the “Credit Agreement”) by and among Holdings, Borrower, the lenders party thereto from time to time (the “Lenders”), and JPMorgan Chase Bank, N.A. as administrative agent (the “Administrative Agent”), which (i) waives any defaults or events of default that may exist or have arisen as a result of Borrower notifying the Administrative Agent and the Lenders that it intends to restate previously delivered financial statements for the fiscal years ending on December 30, 2023 and on December 28, 2024 and the first three fiscal quarters of the fiscal year ending on December 27, 2025, (i”

Organon & Co. entered into Agreement and Plan of Merger with Sun Pharmaceutical Holdings USA, Inc., Sun Pharma America, Inc., Sun Pharmaceutical Industries Limited, Sun Pharma Canada Inc., Sun Pharma (Netherlands) B.V. (effective 2026-04-26).

“On April 26, 2026, Organon & Co. (the “ Company ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Sun Pharmaceutical Holdings USA, Inc., a Delaware corporation (“ Parent ”), Sun Pharma America, Inc., a Delaware corporation and wholly owned subsidiary of Parent and/or its affiliates (“ Merger Sub ”) and, solely for the purposes of certain covered provisions of the Merger Agreement, Sun Pharmaceutical Industries Limited, an entity organized under the laws of India (“ India Parent ”), Sun Pharma Canada Inc., a corporation incorporated under the laws of the Province of Ontario and Sun Pharma (Netherlands) B.V., a private company with limited liability incorporated under the laws of the Netherlands, pursuant to which, among other things, Merger Sub will merge with and into the Company (the “ Merger ”), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent.”

Velo3D, Inc. entered into Underwriting Agreement with Cantor Fitzgerald & Co. valued at approximately $50 million (effective 2026-04-27).

“On April 27, 2026, Velo3D, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cantor Fitzgerald & Co., as underwriter (the “Underwriter”), relating to the offer and sale in a firm commitment underwritten registered direct offering (the “Offering”) of 3,571,428 shares (the “Shares”) of the Company’s common stock, par value $0.00001 per share.”

Profusa, Inc. entered into Asset Purchase Agreement with Bio Insights LLC valued at $30,000,000 (effective 2026-04-21).

“On April 21, 2026, Profusa Inc., a Delaware corporation (the “ Company ”), and Bio Insights LLC, a limited liability company (“ Seller ”), entered into an Asset Purchase Agreement (the “ Asset Purchase Agreement ”) pursuant to which Seller agreed to sell, convey, assign, transfer, and deliver to the Company substantially all of the know-how assets relating to Seller’s PanOmics Assay”

Yesway, Inc. entered into Registration Rights Agreement with the Company and each other Person identified on the Schedule of Holders (effective 2026-04-21).

“a Registration Rights Agreement, dated April 21, 2026, by and among the Company and each other Person identified on the Schedule of Holders (as defined therein) attached thereto”

Yesway, Inc. entered into Stockholders Agreement with the Company and the Brookwood Parties (effective 2026-04-21).

“• a Stockholders Agreement, dated April 21, 2026, by and among the Company and the Brookwood Parties (as defined therein), a copy of which is filed as Exhibit 10.3 to this Current Report”

Yesway, Inc. entered into Fourth Amended and Restated Limited Liability Company Agreement of BW Ultimate Parent, LLC with BW Ultimate Parent, LLC, the Company and the other Members (effective 2026-04-21).

“a Fourth Amended and Restated Limited Liability Company Agreement of BW Ultimate Parent, LLC, dated April 21, 2026, by and among BW Ultimate Parent, LLC, the Company and the other Members (as defined therein)”

Yesway, Inc. entered into Tax Receivable Agreement with BW Ultimate Parent, LLC, the TRA Parties, the Brookwood Nominee (effective 2026-04-21).

“a Tax Receivable Agreement, dated April 21, 2026, by and among the Company, BW Ultimate Parent, LLC, the TRA Parties (as defined therein), the Brookwood Nominee (as defined therein), and each of the other Persons (as defined therein) from time to time party thereto”

Golub Capital Private Credit Fund amended Fifth Amendment with Sumitomo Mitsui Banking Corporation valued at $2.6025 billion to $3.1275 billion (effective 2026-04-23).

“On April 23, 2026, Golub Capital Private Credit Fund (“ GCRED ”) entered into the fifth amendment (the “ Fifth Amendment ”) to the senior secured revolving credit facility, dated as of September 6, 2023”

Andretti Acquisition Corp. II amended Amended and Restated Promissory Notes with William J. Sandbrook, Michael Andretti and William M. Brown valued at aggregate total amended to $4,375,000 (effective 2026-04-27).

“On April 27, 2026, the Company amended and restated the Original Notes (the “ Amended and Restated Notes ”) to increase the total principal amounts to $2,100,000, $875,000 and $1,400,000, respectively, for a revised aggregate total of $4,375,000.”

Miluna Acquisition Corp entered into Business Combination Agreement with Kukugan Invest valued at Aggregate Transaction Consideration Value of $250,000,000; earn-out of up to 5,000,000 PubCo Class A (effective 2026-04-23).

“On April 23, 2026, Miluna Acquisition Corp, a Cayman Islands exempted company (“ Miluna ” or “ Purchaser ”), entered into a definitive Business Combination Agreement (the “ Business Combination Agreement ”) with Kukugan Invest, a Cayman Islands exempted company (“ Parent ”), and CADV Ventures S.A., a Poland company and a wholly-owned Subsidiary of Parent (the “ Company ”).”

DMC Global Inc. amended Amendment No. 2 to Stockholder Protection Rights Agreement with Computershare Trust Company, N.A. (effective 2026-04-24).

“On April 24, 2026, DMC Global Inc. (the “Company”) entered into Amendment No. 2 to Stockholder Protection Rights Agreement (“Amendment No. 2”), which further amends that certain Stockholder Protection Rights Agreement, dated as of June 5, 2024, by and between the Company and Computershare Trust Company, N.A., as rights agent (the “Original Rights Agreement”), as amended by that certain Amendment No. 1 to Stockholder Protection Rights Agreement, dated as of May 30, 2025 (“Amendment No. 1”).”

TRIO-TECH INTERNATIONAL entered into Placement Agent Agreement with D. Boral Capital LLC valued at 4.5% of the aggregate gross proceeds (effective 2026-04-24).

“Additionally, on April 24, 2026, the Company also entered into a placement agent agreement (the “ Placement Agent Agreement ”) with D. Boral Capital LLC (the “ Placement Agent ”).”

TRIO-TECH INTERNATIONAL entered into Purchase Agreement with the purchaser signatories thereto valued at $9.50 per share (effective 2026-04-24).

“On April 24, 2026, Trio-Tech International, a California corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with the purchaser signatories thereto (the “ Purchasers ”), which provides for the sale and issuance by the Company in a registered direct offering (the “ Offering ”) of an aggregate of 1,052,632 shares of the Company’s common stock, no par value (the “ Common Stock ”), at a purchase price of $9.50 per share (the “ Shares ”).”

XOMA Royalty Corp entered into Merger Agreement with Ligand Pharmaceuticals Incorporated and Flex Merger Sub, Inc. (effective 2026-04-27).

“On April 27, 2026, XOMA Royalty Corporation, a Nevada corporation (the “ Company ” or “ XOMA Royalty ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, Ligand Pharmaceuticals Incorporated, a Delaware corporation (“ Parent ”), and Flex Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of Parent (“ Merger Sub ”)”

OPPENHEIMER HOLDINGS INC entered into Settlement Term Sheet with Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated valued at $70 million (effective 2026-04-24).

“On April 24, 2026, Oppenheimer & Co., Inc. (“Oppenheimer”), the principal operating subsidiary of Oppenheimer Holdings Inc. (the “Company”), reached an agreement to settle the previously disclosed litigation styled Liberty Capital Group, Individually and on Behalf of All Others Similarly Situated v. Oppenheimer Holdings Inc., Oppenheimer & Co. Inc., and Oppenheimer Asset Management Inc. , No. 1:25-cv04822-JSR which was filed in the United States District Court for the Southern District of New York in June of 2025 (the “ District Court”).”

LIGAND PHARMACEUTICALS INC entered into Agreement and Plan of Merger with XOMA Royalty Corporation (effective 2026-04-27).

“On April 27, 2026, Ligand Pharmaceuticals Incorporated, a Delaware corporation (“ Ligand ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among Ligand, XOMA Royalty Corporation, a Nevada corporation (“ XOMA Royalty ”), and Flex Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of Ligand (“ Merger Sub ”)”

PDF SOLUTIONS INC amended First Amendment to Credit Agreement with Wells Fargo Bank, National Association valued at $75 million (effective 2026-04-23).

“On April 23, 2026, PDF Solutions, Inc. (the “ Company ”) entered into a First Amendment to Credit Agreement (the “ Amendment ”), by and among the Company, the subsidiary guarantors party thereto, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent to the lenders.”

Ultra Clean Holdings, Inc. amended Tenth Amendment with Barclays Bank PLC, as administrative agent, and the revolving lenders and other parties thereto valued at $250 million (effective 2026-04-23).

“On April 23, 2026, Ultra Clean Holdings, Inc. (the “Company“) and the other parties thereto entered into that certain Tenth Amendment (the “Amendment“) to its Credit Agreement originally dated as of August 27, 2018 (as amended by the Amendment, the “Credit Agreement“), among the Company, as parent borrower, Barclays Bank PLC, as administrative agent, and the revolving lenders and other parties thereto.”

Altimmune, Inc. entered into Underwriting Agreement with Leerink Partners LLC and Barclays Capital Inc., as representatives of the several underwriters valued at approximately $211.2 million (effective 2026-04-22).

“On April 22, 2026, Altimmune, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Leerink Partners LLC and Barclays Capital Inc., as representatives of the several underwriters named therein (the “ Underwriters ”) pursuant to which the Company agreed to issue and sell (i) 64,250,000 shares of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) and accompanying common stock warrants to purchase shares of Common Stock (the “ Common Stock Warrants ”), to the Underwriters at a public offering price of $3.00 per share and (ii) in lieu of Common Stock to certain investors that so choose, pre-funded warrants (the “ Pre-Funded Warrants ” and together with the Common Stock Warrants, the “ Warrants ”) to purchase up to 10,750,000 shares of Common Stock to the Underwriters at a public offering price of $2.999 per Pre-Funded Warrant (the “ Offering ”).”